Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Clinical diagnosis of stable mild-to-moderate plaque-type psoriasis involving 2-35% of total body surface area (BSA) excluding face, scalp, and genitals
Willingness and ability to apply study medication as directed, comply with study instructions, and commit to attending all study visits
Women of childbearing potential must agree to use contraception for the entire study period
You may not be if
Any dermatological conditions that could interfere with clinical evaluations
Concurrent or recent use of certain topical or systemic medications without a sufficient washout period
Significant confounding conditions as assessed by study doctor
Participated in any other trial of an investigational drug within 30 days or participation in a research study concurrent with this study
Use of lithium- or hydroxychloroquine-containing products (e.g., Plaquenil)
Use of a beta-blocking medication (e.g., propranolol) if the dose has not been stabilized for at least 3 months
